Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30239% above fair value
$4.30−0.24 (-5.29%)
Close on Nov 16, 2026Market cap $1.54BP/E 107.5Yield –
Precigen profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Precigen's profit margin for the twelve months ending Sep 30, 2026 was 15.6%. For fiscal 2025 it was -2588.2%, against -3216.2% the year before. The highest annual figure on record is 105.2% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2588.2% | +628.0 |
| FY2024 | Dec 31, 2024 | -3216.2% | −1675.6 |
| FY2023 | Dec 31, 2023 | -1540.6% | −1645.9 |
| FY2022 | Dec 31, 2022 | 105.2% | +751.2 |
| FY2021 | Dec 31, 2021 | -646.0% | −113.0 |
| FY2020 | Dec 31, 2020 | -533.0% | −177.7 |
| FY2019 | Dec 31, 2019 | -355.3% | −18.4 |
| FY2018 | Dec 31, 2018 | -336.9% | −283.6 |
| FY2017 | Dec 31, 2017 | -53.3% | +44.4 |
| FY2016 | Dec 31, 2016 | -97.7% | −49.1 |
| FY2015 | Dec 31, 2015 | -48.7% | +65.1 |
| FY2014 | Dec 31, 2014 | -113.8% | +50.3 |
| FY2013 | Dec 31, 2013 | -164.1% | +430.4 |
| FY2012 | Dec 31, 2012 | -594.4% | +469.9 |
| FY2011 | Dec 31, 2011 | -1064.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 48.2% | +5056.6 |
| Q2 FY2026 | Jun 30, 2026 | 36.5% | +3148.9 |
| Q1 FY2026 | Mar 31, 2026 | -34.1% | +4004.2 |
| Q4 FY2025 | Dec 31, 2025 | -514.9% | +635.1 |
| Q3 FY2025 | Sep 30, 2025 | -5008.4% | −3780.1 |
| Q2 FY2025 | Jun 30, 2025 | -3112.4% | −1854.5 |
| Q1 FY2025 | Mar 31, 2025 | -4038.3% | −4560.8 |
| Q2 FY2023 | Jun 30, 2023 | -1149.9% | −544.1 |
| Q1 FY2023 | Mar 31, 2023 | -1228.2% | −879.0 |
| Q4 FY2022 | Dec 31, 2022 | -1257.9% | −578.3 |
| Q3 FY2022 | Sep 30, 2022 | 522.5% | +1415.5 |
| Q2 FY2022 | Jun 30, 2022 | -605.8% | −80.2 |
| Q1 FY2022 | Mar 31, 2022 | -349.2% | −278.5 |
| Q4 FY2021 | Dec 31, 2021 | -679.5% | −464.0 |
| Q3 FY2021 | Sep 30, 2021 | -893.0% | −767.9 |
| Q2 FY2021 | Jun 30, 2021 | -525.6% | −383.1 |
| Q1 FY2021 | Mar 31, 2021 | -70.7% | +117.0 |
| Q4 FY2020 | Dec 31, 2020 | -215.5% | +779.8 |
| Q3 FY2020 | Sep 30, 2020 | -125.1% | +168.0 |
| Q2 FY2020 | Jun 30, 2020 | -142.5% | −24.4 |
| Q1 FY2020 | Mar 31, 2020 | -187.7% | +81.1 |
| Q4 FY2019 | Dec 31, 2019 | -995.3% | −168.7 |
| Q3 FY2019 | Sep 30, 2019 | -293.1% | −102.4 |
| Q2 FY2019 | Jun 30, 2019 | -118.1% | +34.8 |
| Q1 FY2019 | Mar 31, 2019 | -268.8% | −144.6 |
| Q4 FY2018 | Dec 31, 2018 | -826.5% | −791.1 |
| Q3 FY2018 | Sep 30, 2018 | -190.7% | −104.5 |
| Q2 FY2018 | Jun 30, 2018 | -152.9% | −118.6 |
| Q1 FY2018 | Mar 31, 2018 | -124.2% | −65.5 |
| Q4 FY2017 | Dec 31, 2017 | -35.4% | +60.5 |
| Q3 FY2017 | Sep 30, 2017 | -86.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -34.3% | – |
| Q1 FY2017 | Mar 31, 2017 | -58.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -95.9% | – |
See a number that looks wrong?